{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:50:48Z","timestamp":1790175048161,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mayoclinicproceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.mayocp.2015.10.018","type":"journal-article","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T02:02:18Z","timestamp":1449972138000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women"],"prefix":"10.1016","volume":"91","author":[{"given":"Aditya","family":"Bardia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya E.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon O.","family":"Ebbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DeAnn","family":"Lazovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Vierkant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine M.","family":"Vachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.mayocp.2015.10.018_bib1","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.mayocp.2015.10.018_bib2","unstructured":"National Cancer Institute. SEER Stat Fact Sheets: Breast Cancer Statistics. SEER website. http:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. Accessed August 10, 2015."},{"issue":"5","key":"10.1016\/j.mayocp.2015.10.018_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","article-title":"Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U. S. Preventive Services Task Force","volume":"146","author":"Rostom","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.10.018_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.10.018_bib5","first-page":"559","article-title":"Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)","volume":"13","author":"Harris","year":"2005","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2015.10.018_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.10.018_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"issue":"9826","key":"10.1016\/j.mayocp.2015.10.018_bib8","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-2999(76)90044-3","article-title":"Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse","volume":"37","author":"Hial","year":"1976","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.10.018_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1476-5381.1977.tb07527.x","article-title":"Effects of aspirin-like drugs on canine gastric mucosal blood flow and acid secretion","volume":"60","author":"Bennett","year":"1977","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.mayocp.2015.10.018_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/bjc.1983.251","article-title":"Prostaglandins in breast cancer: relationship to disease stage and hormone status","volume":"48","author":"Karmali","year":"1983","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.mayocp.2015.10.018_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0277-5379(85)90290-1","article-title":"Prostaglandins, steroids and human mammary cancer","volume":"21","author":"Watson","year":"1985","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2005.09.112","article-title":"Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention","volume":"23","author":"Dannenberg","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.steroids.2007.09.011","article-title":"Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition","volume":"73","author":"Su","year":"2008","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","article-title":"Aspirin use and lung, colon, and breast cancer incidence in a prospective study","volume":"5","author":"Schreinemachers","year":"1994","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/pmed.1995.1022","article-title":"Breast cancer and NSAID use: heterogeneity of effect in a case-control study","volume":"24","author":"Harris","year":"1995","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","article-title":"Nonsteroidal antiinflammatory drugs and breast cancer","volume":"7","author":"Harris","year":"1996","journal-title":"Epidemiology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/pmed.1999.0518","article-title":"The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer","volume":"29","author":"Coogan","year":"1999","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","article-title":"Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage","volume":"83","author":"Sharpe","year":"2000","journal-title":"Br J Cancer"},{"issue":"20","key":"10.1016\/j.mayocp.2015.10.018_bib20","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","article-title":"Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk","volume":"291","author":"Terry","year":"2004","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mayocp.2015.10.018_bib21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/dji140","article-title":"Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status","volume":"97","author":"Marshall","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.mayocp.2015.10.018_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2407-5-159","article-title":"Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer","volume":"5","author":"Rahme","year":"2005","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/aje\/kwi182","article-title":"Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited","volume":"162","author":"Zhang","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.10.018_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/aje\/kwm216","article-title":"Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings","volume":"166","author":"Kirsh","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.10.018_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10549-007-9665-x","article-title":"NSAID use and breast cancer risk in the VITAL cohort","volume":"109","author":"Ready","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"10.1016\/j.mayocp.2015.10.018_bib26","first-page":"6096","article-title":"Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative","volume":"63","author":"Harris","year":"2003","journal-title":"Cancer Res"},{"issue":"14","key":"10.1016\/j.mayocp.2015.10.018_bib27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/jnci\/88.14.988","article-title":"Prospective study of regular aspirin use and the risk of breast cancer","volume":"88","author":"Egan","year":"1996","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1055-9965.261.14.1","article-title":"Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort","volume":"14","author":"Jacobs","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.mayocp.2015.10.018_bib29","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/aje\/kwm195","article-title":"Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort","volume":"166","author":"Gill","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib30","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/bcr2089","article-title":"Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study","volume":"10","author":"Gierach","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"12","key":"10.1016\/j.mayocp.2015.10.018_bib31","first-page":"1586","article-title":"Association of aspirin and other nonsteroidal anti-inflammatory drug use with breast cancer","volume":"11","author":"Johnson","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.mayocp.2015.10.018_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1158\/1940-6207.CAPR-10-0101","article-title":"Two good choices to prevent breast cancer: great taste, less filling","volume":"3","author":"Hortobagyi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"10.1016\/j.mayocp.2015.10.018_bib33","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/oxfordjournals.aje.a115570","article-title":"Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women","volume":"131","author":"Folsom","year":"1990","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.mayocp.2015.10.018_bib34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/oxfordjournals.aje.a116948","article-title":"Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up","volume":"139","author":"Bisgard","year":"1994","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.mayocp.2015.10.018_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jnci\/djq526","article-title":"Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies","volume":"103","author":"Yang","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.mayocp.2015.10.018_bib36","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.mayocp.2015.10.018_bib37","unstructured":"Ries LAG, Melbert D, Krapcho M, et\u00a0al, eds. SEER Cancer Statistics Review, 1975-2005. SEER website. http:\/\/seer.cancer.gov\/csr\/1975_2005\/. Published 2008. Accessed August 10, 2015."},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-010-1074-x","article-title":"Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study","volume":"126","author":"Bardia","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/oxfordjournals.aje.a009034","article-title":"Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale","volume":"145","author":"Korn","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2011.04.009","article-title":"Number needed to treat is incorrect without proper time-related considerations","volume":"65","author":"Suissa","year":"2012","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"28","key":"10.1016\/j.mayocp.2015.10.018_bib41","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1200\/JCO.2012.42.2006","article-title":"Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence","volume":"30","author":"Zhang","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"7250","key":"10.1016\/j.mayocp.2015.10.018_bib42","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","article-title":"Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database","volume":"320","author":"Langman","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib43","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-011-1747-0","article-title":"Aspirin use and breast cancer risk: a meta-analysis","volume":"131","author":"Luo","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women's Health Study; a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.mayocp.2015.10.018_bib45","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","article-title":"Aspirin intake and survival after breast cancer","volume":"28","author":"Holmes","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.10.018_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10549-006-9277-x","article-title":"NSAID use and survival after breast cancer diagnosis in post-menopausal women","volume":"101","author":"Blair","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-015-3300-z","article-title":"Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies","volume":"150","author":"Zhong","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.mayocp.2015.10.018_bib48","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jnci\/djh025","article-title":"Risk factors for breast cancer according to estrogen and progesterone receptor status","volume":"96","author":"Colditz","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.mayocp.2015.10.018_bib49","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/cncr.21763","article-title":"Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease","volume":"106","author":"Gallicchio","year":"2006","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.mayocp.2015.10.018_bib50","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2015.10.018_bib51","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1038\/emm.2013.91","article-title":"Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells","volume":"45","author":"Choi","year":"2013","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.mayocp.2015.10.018_bib52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2407-14-141","article-title":"Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mayocp.2015.10.018_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-3-28","article-title":"Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis","volume":"3","author":"Gonz\u00e1lez-P\u00e9rez","year":"2003","journal-title":"BMC Cancer"},{"issue":"15","key":"10.1016\/j.mayocp.2015.10.018_bib54","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199404143301501","article-title":"The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers","volume":"330","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2015.10.018_bib55","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial","volume":"293","author":"Lonn","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"301","author":"Lippman","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2015.10.018_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2008.862","article-title":"Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial","volume":"301","author":"Gaziano","year":"2009","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.mayocp.2015.10.018_bib58","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/1940-6207.CAPR-10-0141","article-title":"Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research","volume":"3","author":"Brewster","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"10.1016\/j.mayocp.2015.10.018_bib59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1470-2045(11)70030-4","article-title":"Preventive therapy for breast cancer: a consensus statement","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2015.10.018_bib60","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.seminoncol.2010.05.004","article-title":"Breast cancer prevention trials: large and small trials","volume":"37","author":"Arun","year":"2010","journal-title":"Semin Oncol"},{"key":"10.1016\/j.mayocp.2015.10.018_bib61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-642-10858-7_13","article-title":"Chemoprevention of hormone receptor-negative breast cancer: new approaches needed","volume":"188","author":"Uray","year":"2011","journal-title":"Recent Results Cancer Res"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615008538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615008538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T04:15:45Z","timestamp":1692159345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619615008538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0025619615008538"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.10.018","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}